Mexico is set to make a significant investment in healthcare infrastructure with the acquisition of 816 high-tech medical devices nationwide, scheduled for delivery throughout 2026. The total investment is estimated at MX$11.3 billion (US$619 million), based on reference prices from a large-scale purchase conducted by IMSS in 2025.

The procurement package includes a wide range of equipment, reflecting the country’s commitment to improving diagnostics and cancer treatment capabilities. Among the devices are 25 linear accelerators for cancer therapy, 238 CT scanners, 38 MRI systems, nearly 500 mammography units, and five PET-CT systems for oncology diagnostics. Additional equipment such as gamma cameras, angiography systems, and brachytherapy units are also part of the plan.

Distribution of the devices spans multiple institutions. Of the 816 units, 341 will go to IMSS, 178 to ISSSTE, 237 to IMSS Bienestar across 24 states, 41 to PEMEX health services, and 19 to the National Institutes of Health in Mexico City.

Mammography units make up one of the largest segments, with nearly 500 units planned for all states, at an estimated cost of MX$1.682 billion (US$96.9 million). CT scanners are projected at an estimated MX$4.8 billion (US$274 million), while 38 MRI systems—the largest consolidated purchase of their kind in Mexico—are valued at MX$1.4 billion (US$79.4 million). Cancer treatment capacity will also expand with the addition of 25 linear accelerators, representing MX$2.59 billion (US$148 million) in investment.

The procurement process will follow a competitive dialogue and reverse auction model, aiming to source equipment directly from manufacturers under defined delivery, warranty, and pricing conditions. Contract awards are expected within the next two months, with phased delivery continuing through 2026.

This initiative represents a major step forward in Mexico’s efforts to modernize healthcare services, expand diagnostic capacity, and strengthen cancer treatment infrastructure across the nation.